eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-ENGN-enGene Therapeutics Inc

enGene Therapeutics Inc ENGN

‎$‎7.970.08(1.01%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Price Target
26.83
Based on analysts who covered ENGN
Invest in enGene Therapeutics Inc
Today
Create an eToro account to buy ENGN stock on a secure, user-friendly, multi-asset trading platform.
Buy enGene Therapeutics Inc
enGene Therapeutics Inc ENGN
Buy ENGN

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

enGene Therapeutics Inc News

ENGN Stock Price Chart

‎21.49‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset stable trend

The enGene Therapeutics Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The enGene Therapeutics Inc share price today is ‎$‎7.97, reflecting a ‎1.01‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of ENGN is ‎$‎528.55M with an average volume in the last three months of 393464.3. The stock has a P/E ratio of -3.5 and a dividend yield of 0%. With the stock’s beta sitting at 0.51
ENGN Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎528.55M
Day’s Range
i
Shows the high and low prices of the day.
‎$‎7.8 - ‎$‎8.14
52W Range
i
Shows the high and low prices of the last year.
‎$‎2.58 - ‎$‎12.19
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
393464.3
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-3.5
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎7.89
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-2.25
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.51

How can I buy enGene Therapeutics Inc stocks?

To purchase enGene Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the enGene Therapeutics Inc (ENGN) page and place an order to buy enGene Therapeutics Inc.
Buy ENGN
Looking for more information? Check out our guide on Academy.
What Is enGene Therapeutics Inc?
enGene Holdings Inc is a biotechnology firm that specialises in developing therapeutic solutions for a variety of complicated genetic disorders. The company’s operation spans across different regions, making its medical innovations available to a wide-reaching patient population.

In the biotechnology sector, enGene Holdings Inc stands out for its focus on gene therapy. With a diverse portfolio of promising products and services, it is a player in the realm of genetic medicine, enhancing the treatment prospects for numerous debilitating diseases.

Add ENGN to your eToro watchlist.
CEO
Ronald Harold Wilfred Cooper
Employees
82
Founded
2023
HQ
Saint-Laurent, Québec, CA
Media Services
NASDAQ
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
What Is Leverage and Margin?
What Is Leverage and Margin?
Leverage means using capital borrowed from a broker when opening a position. Sometimes traders may wish to apply leverage in order to obtain more exposure than the amount deposited, as part of their investment strategy.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
Go to the Academy >
Graph
Buy enGene Therapeutics Inc
Invest in enGene Therapeutics Inc
Today
Create an eToro account to buy ENGN stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of ENGN is ‎$‎7.97.
The average price target for enGene Therapeutics Inc is ‎$‎26.83. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for enGene Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of enGene Therapeutics Inc is ‎$‎528.55M
Based on 6 analysts offering recommendations for ENGN in the last 3 months, the overall consensus is .
Daily Movers
Explore the biggest stocks movers on the market.
Buy ENGN
English (UK)English (UK)Check icon
DeutschDeutsch
FrançaisFrançais
PolskiPolski
PortuguêsPortuguês
DanskDansk
SuomiSuomi
EspañolEspañol
РусскийРусский
العربيةالعربية
NederlandsNederlands
SvenskaSvenska
RomânăRomână
ItalianoItaliano
中文中文
繁體中文繁體中文
NorskNorsk
ČeštinaČeština
Tiếng ViệtTiếng Việt
ΕλληνικάΕλληνικά
Scroll to top